Benzonatate

CHEMBL1374379 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
603.7 g/mol
LogP
2.4
Phase
4

A non-narcotic cough suppressant that works by numbing the stretch receptors in the airways and lungs, reducing the urge to cough. It is used to relieve uncomfortable, nonproductive coughing. Unlike opioid cough medicines, it does not affect the brain's cough center.

分子量

603.7000 g/mol

LogP

2.40

TPSA

121.00 Ų

リピンスキーの五則

不適合

作用機序

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1

InChI

InChI=1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3

Molecular Formula

C30H53NO11

HBD / HBA

1 / 12

回転可能結合数

33

重原子数

42

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A non-narcotic cough suppressant that works by numbing the stretch receptors in the airways and lungs, reducing the urge to cough. It is used to relieve uncomfortable, nonproductive coughing. Unlike opioid cough medicines, it does not affect the brain's cough center.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Benzonatate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1374379. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 7699. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.